Sol-gel technologies stock
WebJan 27, 2024 · Sol-Gel broadens its pipeline with this new chemical entity, designated as investigational compound SGT-610, which has the potential to be the first-ever drug for treatment of Gorlin syndrome. Sol-Gel expects the transaction to close on or about January 30, 2024, subject to the satisfaction of customary closing conditions. WebFeb 2, 2024 · Currently, Sol Gel Technologies Ltd’s price-earnings ratio is 30.9. Sol Gel Technologies Ltd’s trailing 12-month revenue is $24.6 million with a 19.9% profit margin. Year-over-year quarterly sales growth most recently was -96.6%. Analysts expect adjusted earnings to reach $-0.520 per share for the current fiscal year.
Sol-gel technologies stock
Did you know?
WebMar 10, 2024 · SLGL Stock News SLGL - Sol-Gel Technologies Ltd. 03/20/23 7:00 AM. Nasdaq: ... About Sol-Gel Technologies Ltd. Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
WebDaily Sol Gel Technologies Ltd (SLGL) Moving Average Analysis with its Strength & Direction Weekly Monthly. Code Price Previous Price Price Change Latest Volume 5 Period Avg Volume; SLGL: 4.07: 3.805: 6.96 %: 13170: 5 9294: About Strength . Key EMA Moving Averages of Sol Gel Technologies Ltd. EMA Value Strength Signal Latest CO CO Type … WebApr 12, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Sol-Gel Technologies stock is Buy based on the current 1 hold rating, 1 buy …
WebApr 6, 2024 · Sol Gel Technologies Ltd (SLGL) stock is trading at $3.75 as of 2:46 PM on Thursday, Apr 6, an increase of $0.09, or 2.46% from the previous closing price of $3.66. The stock has traded between $3.65 and $3.85 so far today. Volume today is below average. So far 5,429 shares have traded compared to average volume of 18,788 shares. WebDec 31, 2024 · Shares of Sol-Gel Technologies (SLGL 2.74%) rose as much as 36.2% today after the company announced positive results for its acne treatment Twyneo in multiple phase 3 clinical trials.
WebDec 30, 2024 · Sol Gel Technologies (SLGL) news for Monday concerning an acne drug study with incredibly positive results has SLGL stock taking off. Free Report 11 Best Stocks to Buy for 2024
WebMar 18, 2024 · With Sol Gel Technologies stock trading at $3.44 per share, the total value of Sol Gel Technologies stock (market capitalization) is $79.57M. Sol Gel Technologies stock was originally listed at a price of $13.64 in Feb 1, 2024. If you had invested in Sol Gel Technologies stock at $13.64, your return over the last 5 years would have been -74.78% ... bing crosby grandchildrenWebApr 14, 2024 · Sol-Gel Technologies Stock Performance. Shares of Sol-Gel Technologies stock opened at $4.07 on Wednesday. The stock has a 50 day moving average price of … cytoplasm egg cellWebSol-Gel Technologies Ltd. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine … cytoplasme procaryoteWebYou can buy and sell Sol-Gel Technologies (SLGL) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. ... bing crosby greatest hitsWebMar 31, 2024 · Complete Sol-Gel Technologies Ltd. stock information by Barron's. View real-time SLGL stock price and news, along with industry-best analysis. cytoplasmesWebMar 27, 2024 · Sol-Gel Technologies stock price target cut to $18 from $21 at Raymond James Mar. 25, 2024 at 7:55 a.m. ET by Tomi Kilgore Dermira shares drop 66% after … bing crosby gravesiteWebNov 4, 2024 · NESS ZIONA, Israel, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL), (“Sol-Gel”), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced a new … cytoplasm electron micrograph